Preclinical and in vitro studies examine CJC-1295 (no DAC) in relation to GHRH receptor signaling and short, pulsatile GH-related signaling patterns in experimental models.
Preclinical and in vitro studies examine CJC-1295 (no DAC) in relation to GHRH receptor signaling and short, pulsatile GH-related signaling patterns in experimental models.